Medical Letter on the CDC & FDA
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC & FDA
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
CVRx, Inc.
Millions of Patients May Find Hope in a New Implantable Device Designed to Lower High Blood Pressure in Drug Resistant Hypertension Patients
May 18th, 2008
May is Hypertension Awareness Month, and a new device in high blood pressure clinical trials is showing promise for treating U.S. hypertension (high blood pressure) patients whose condition is not controlled by drugs. Rheos(R) Hypertension (HT) Therapy is an implantable device designed to lower high blood pressure -- the number one risk factor for stroke, heart and kidney disease. "The Rheos Device is an innovative treatment approach for patients unable to control their high blood pressure with conventional medications," said Nadim Yared, CVRx president and CEO. "The Rheos system is designed to reduce patients' blood pressure by utilizing the body's own...
Source: Medical Letter on the CDC & FDA (2008-05-18)
|
